Exhaled Nitric Oxide, Bronchial Hyperresponsiveness and Spirometric Parameters in Patients with Allergic Rhinitis during Pollen Season
-
Michael P Makris
,
Christina Gratziou
,
Xenophon S. Aggelides
,
Sokratis P. Koulouris
,
Ioanna Koti
,
Dimitrios C Kalogeromitros
Abstract
Allergic rhinitis and asthma share common epidemiological features and inflammatory processes. The aim of the present study was to document the influence of natural allergen exposure in exhaled NO (eNO) and in spirometric parameters of patients with seasonal allergic rhinitis(SAR) and to investigate the differences among subjects with positive versus negative bronchial provocation to metacholine(BPMch).
Twenty-six non-smoking patients (13F/13M; mean age 28.4ys) with a documented history of SAR, 15 healthy, non-atopic(6F/9M; mean age 37.1ys) and 6 non-symptomatic atopic subjects (3F/3M; mean age 36.5ys) were studied. At the first visit during pollen season each subject filled symptom-score card, underwent eNO and nasal NO (nNO) measurements and spirometry. BPMch was performed within the next 10 days. At the second visit out of pollen season, all measurements but BPMch were repeated. Control subjects underwent eNO and nNO measurements.
eNO was significantly increased during pollen season in BPMch positive vs BPMch negative(46.22±32.60 vs 17.81±12.67, p=0.014) and vs non-atopic controls(11.40±5.84, p<0.001) as well as atopic controls(13.56±5.34, p=0.001). No difference was detected out of pollen season in both patients’ groups. nNO values were increased only in BPMch(+) group compared to both control groups in pollen season (vs non-atopics p=0.002, vs atopics p=0.002) and only vs non-atopics out of season, p=0.004. Regression analysis has shown that the difference in FEF25-75 values (off season-in season) is a predictor of positive BPMch.
eNO is markedly increased in BPMch patients with allergic rhinitis while mid-expiratory flow may represent an early marker of lower airway involvement in respiratory allergy.
1. Ait-Khaled N, Pearce N, Anderson HR, Ellwood P, Montefort S, Shah J. The ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009; 64 (1):123-48.
2. Linneberg A, Nielsen N, Frolund L, Madsen F, Dirksen A, Jorgensen T. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002;57(11):1048-1052.
3. Togias A. Systemic cross-talk between the lung and the nose. Am J Respir Crit Care Med 2001; 164(5):726-7.
4. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26 (5):948–68.
5. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR,Hegele RG, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100(1):44–51.
6. Ciprandi G, Cirillo I, Vizzaccaro A, Tosca M, Passalacqua G, Pallestrini E, et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? A population based study. Allergy 2005; 60(7):882–7.
7. Ciprandi G, Cirillo I, Klersy C, Marseglia GL, Vizzaccaro A, Pallestrini E, et al. Role of FEF25–75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis. Am J Rhinol 2006; 20(6):641–7.
8. Ciprandi G, Cirillo I, Tosca MA, Vizzaccaro A.Bronchial hyperreactivity and spirometric impairment in patients with perennial allergic rhinitis. Int Arch Allergy Immunol 2004; 133(1):14–8.
9. Polosa R, Ciamarra I, Mangano G, Prosperini G, Pistorio MP, Vancheri C, et al. Bronchial hypperesponsiveness and airway inflammation markers in non asthmatics with allergic rhinitis. Eur Respir J 2000; 15(1):30-35.
10. Porsbjerg C, von Linstow ML, Ulric CS, Nepper-Christensen SC, Backer V. Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood. Ann Allergy Asthma Immunol 2005; 95(2):137-42.
11. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153(1):454-7.
12. Jouaville LF, Annesi-Maesano I, Nguyen LT, Bocage AS, Bedu M, Caillaud D. Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population- based sample of children. Clin Exp Allergy 2003;33(11):1506–11.
13. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, et al. Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis. Allergy 2004; 59:320-6.
14. Bousquet J, Khaltaev N, Cruz AA, Denburg J, FokkensWJ, Togias A et al. World Health Organization; GA(2)LEN; AllerGen: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**). Allergy 2008: 63 (Suppl. 86): 8–160
15. Ciprandi G, Buscaglia S, Pesce G, Pronzato C, Ricca V,Parmiani S, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995;96(6 Pt 1):971–9.
16. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005: Am J Respir Crit Care Med 2005;171(8):912-30.
17. Gratziou C, Lignos M, Dassiou M, Roussos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999; 14(4):897-901.
18. Gratziou C, Rovina N, Makris M, Simoes DM, Papapetropoulos A, Roussos C. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol 2008;21(4):949-57.
19. Cardinale F, de Benedictis FM, Muggeo V, Giordano P, Loffredo MS, Iacoviello G, et al. Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis. Pediatr Allergy Immunol 2005; 16(3):236-42.
20. Jouaville LF, Annesi-Maesano I, Nguyen LT, Bocage AS, Bedu M, Caillaud D, et al. Interrelationships among asthma, atopy, rhinitis and exhaled nitiric oxide in a population-based sample of children. Clin Exp Allergy2003; 33(11):1506-11.
21. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, et al. Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis. Allergy 2004; 59(3):320-6.
22. Horvath I, Barnes PJ. Exhaled monoxides in asymptomatic atopic subjects. Clin Exp Allergy 1999;29(9):1276-80.
23. Prasad A, Langford B, Stradling JR, Ho LP. Exhaled nitiric oxide as a screening tool for asthma in school children. Respir Med 2006; 100(1):167-73.
24. Olin AC, Alving K, Toren K. Exhaled nitric oxide relation to sensitization and respiratory symptoms. Clin Exp Allergy 2004; 34(2):221-6.
25. Prieto L, Uixera S, Gutierrez V, Bruno L. Modifications
of Airway Responsiveness to adenosine 5- monophosphate and exhaled nitric oxide Concentrations after the pollen season in subjects with pollen-induced rhinitis. Chest 2002; 122(3):940-7.
26. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53(2):91–5.
27. Langley SJ, Goldthorpe S, Custovic A, Woodcock A.Relationship among pulmonary function, bronchial reactivity, and exhaled nitric oxide in a large group of asthmatic patients. Ann Allergy Asthma Immunol 2003;91(4):398-404.
28. Silvestri M, Spallarossa D, Battistini E, Fregonese B, Rossi GA. Dissociation between exhaled nitric oxide and hyperresponsiveness in children with mild intermittent asthma. Thorax 2000; 55(6):484-8.
29. van Rensen ELJ, Straathof K, Veselic-Charvat M,Zwinderman A, Bel E, Sterk P. Effects of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 1999; 54(5):403-8.
30. Prieto L, Gutierrez V, Uixera S. Exhaled nitric oxide and bronchial responsiveness to adenosine 5-monophosphate Concentrations after the pollen season in subjects with allergic rhinitis. Chest 2002; 122(3):940-7.
31. Porsbjerg C, Brannan JD, Anderson SD, Backer V.Relationship between airway responsiveness to mannitol and to metacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy 2008; 38(1):43-50.
32. Ciprandi G, Cirillo I, Vizzaccaro A, Monardo M, Tosca MA. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity. Respir Med 2005; 99(12):1606-12.
33. Marseglia GL, Cirillo I, Vizzaccaro A, Klersy C, Tosca MA, La Rosa M, et.al. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis. Allergy Asthma Proc 2007; 28(1):74-8.
34. Mete N, Sin A, Gulbahar O, Erdinc M, Sebik F, Kokuludag A. The determinants of bronchial hyperresponsiveness in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2004; 93(2):193–9.
35. Kharitonov SA, Rajakulasingam K, O’Connor B, Durham SR, Barnes PJ. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997;99(1 Pt 1):58–64.
36. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J.Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: Influence of atopy and hayfever on nNO. Am J Rhinol 2006; 20(5):425-9.
37. Ciprandi G, Cirillo I, Klersy C. Lower airways may also be affected in asymptomatic patients with recent allergic rhinitis. Laryngoscope 2010; 120(7):1288-91.
| Files | ||
| Issue | Vol 10, No 4 (2011) | |
| Section | Articles | |
| Keywords | ||
| Allergic rhinitis Asthma Bronchial hyperresponsiveness Exhaled nitric oxide Spirometry | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
